Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”

Pasquale Fatuzzo,* Luca Zanoli,* Viviana Scollo Department of Clinical and Experimental Medicine, Section of Nephrology, University of Catania, Catania, Italy *These authors contributed equally to this work In an article published in a recent issue of Clinical Interventions in Aging, Toprak...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fatuzzo P, Zanoli L, Scollo V
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/ac7bc725902b48b79eb450179fddddb8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ac7bc725902b48b79eb450179fddddb8
record_format dspace
spelling oai:doaj.org-article:ac7bc725902b48b79eb450179fddddb82021-12-02T04:32:20ZLetter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”1178-1998https://doaj.org/article/ac7bc725902b48b79eb450179fddddb82017-04-01T00:00:00Zhttps://www.dovepress.com/letter-regarding-the-article-the-impact-of-hypomagnesemia-on-erec-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Pasquale Fatuzzo,* Luca Zanoli,* Viviana Scollo Department of Clinical and Experimental Medicine, Section of Nephrology, University of Catania, Catania, Italy *These authors contributed equally to this work In an article published in a recent issue of Clinical Interventions in Aging, Toprak et al1 found that, among patients with stage 3–4 chronic kidney disease (CKD), the prevalence of erectile dysfunction was higher in patients with hypomagnesemia. This finding is clinically relevant because it supports the hypothesis that hypomagnesemia may lead to inflammation2 and endothelial dysfunction, two causes of erectile dysfunction. Toprak et al1 concluded that the detection of the serum magnesium level in non-diabetic elderly men with CKD could be useful to assess the risk of erectile dysfunction. Consequently, it is important to assess the causes of hypomagnesemia in patients with CKD, in particular the causes that are potentially reversible. With this in mind, hypomagnesemia could be caused by the long-term use of proton pump inhibitors,2,3 widely used in patients with CKD but not reported in the study of Toprak et al,1 alone or in combination with diuretics2 or cyclosporine.4 View the original paper by Toprak and colleagues Fatuzzo PZanoli LScollo VDove Medical PressarticleProton pump inhibitorshypomagnesemiaerectile dysfunctionchronic kidney diseaseGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 12, Pp 741-743 (2017)
institution DOAJ
collection DOAJ
language EN
topic Proton pump inhibitors
hypomagnesemia
erectile dysfunction
chronic kidney disease
Geriatrics
RC952-954.6
spellingShingle Proton pump inhibitors
hypomagnesemia
erectile dysfunction
chronic kidney disease
Geriatrics
RC952-954.6
Fatuzzo P
Zanoli L
Scollo V
Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
description Pasquale Fatuzzo,* Luca Zanoli,* Viviana Scollo Department of Clinical and Experimental Medicine, Section of Nephrology, University of Catania, Catania, Italy *These authors contributed equally to this work In an article published in a recent issue of Clinical Interventions in Aging, Toprak et al1 found that, among patients with stage 3–4 chronic kidney disease (CKD), the prevalence of erectile dysfunction was higher in patients with hypomagnesemia. This finding is clinically relevant because it supports the hypothesis that hypomagnesemia may lead to inflammation2 and endothelial dysfunction, two causes of erectile dysfunction. Toprak et al1 concluded that the detection of the serum magnesium level in non-diabetic elderly men with CKD could be useful to assess the risk of erectile dysfunction. Consequently, it is important to assess the causes of hypomagnesemia in patients with CKD, in particular the causes that are potentially reversible. With this in mind, hypomagnesemia could be caused by the long-term use of proton pump inhibitors,2,3 widely used in patients with CKD but not reported in the study of Toprak et al,1 alone or in combination with diuretics2 or cyclosporine.4 View the original paper by Toprak and colleagues 
format article
author Fatuzzo P
Zanoli L
Scollo V
author_facet Fatuzzo P
Zanoli L
Scollo V
author_sort Fatuzzo P
title Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
title_short Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
title_full Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
title_fullStr Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
title_full_unstemmed Letter regarding the article “The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
title_sort letter regarding the article “the impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study”
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/ac7bc725902b48b79eb450179fddddb8
work_keys_str_mv AT fatuzzop letterregardingthearticleldquotheimpactofhypomagnesemiaonerectiledysfunctioninelderlynondiabeticstage3and4chronickidneydiseasepatientsaprospectivecrosssectionalstudyrdquo
AT zanolil letterregardingthearticleldquotheimpactofhypomagnesemiaonerectiledysfunctioninelderlynondiabeticstage3and4chronickidneydiseasepatientsaprospectivecrosssectionalstudyrdquo
AT scollov letterregardingthearticleldquotheimpactofhypomagnesemiaonerectiledysfunctioninelderlynondiabeticstage3and4chronickidneydiseasepatientsaprospectivecrosssectionalstudyrdquo
_version_ 1718401209147064320